The Experts in Animal Health

Brakke Consulting’s
Animal Health News & Notes for January 24, 2020
Copyright © Brakke Consulting
Editor: Lynn Fondon DVM MBA

IMPORTANT NOTE: News & Notes will be moving to a new platform next week to better serve you.  If you do not receive the newsletter beginning next week, please look in your spam/junk folder, and mark the newsletter as “not spam” or whitelist it, to continue receiving it.


Brakke Consulting news
2020 Industry Overview at WVC
Pet Health Products report

Earning News
Creso Pharma
National Veterinary Services
Parnell Pharmaceuticals
PetMed Express

Other News
Anubis Bio
Royal Canin

Announcing the 2020 Brakke Industry Overview

Information to keep you ahead of the pack

Presented at WVC: February 18, 2020, 2-4 pm, Four Seasons Hotel, Acacia Ballroom

What do industry consolidation, CBD and African Swine Fever have in common?  They are all important topics covered in Brakke Consulting’s annual Industry Overview presented at VMX and WVC in early 2020.

2019 was an especially newsy year, and many events have long-range implications for the animal health industry.  Key topics and presenters include:

  • Industry performance and a special analysis of the public companies in animal health (Dr. Bob Jones and Randy Freides)
  • Vet practice consolidation, CBD, monoclonal antibodies and other new companion animal technologies (John Volk)
  • Disruptive technologies and the changing landscape of the diagnostics industry (Dr. Mike McGinley)
  • African Swine fever, plant-based meat and milk products and their impact on protein and animal health product demand (Dr. Cary Christensen)

This information-packed 2-hour session will be especially valuable for executive leadership, sales and marketing, strategy and finance managers.

To register, sign up today on our website at  Or email Amanda McDavid or call her at 336-396-3916.  Pre-registration cost for WVC is $400; there are discounts for multiple attendees from the same company.  We look forward to seeing you there!



  • Virbac SA reported results for the full year 2019. Revenue rose to EUR 938 million ($1,050 million), an increase of 8% compared to the prior year. Adjusted for the positive impact of exchange rates, revenue showed growth of 6.6%. In the United States, the business grew by 19% at actual exchange rates (+14% at constant exchange rates). (Globe newswire)
  • Parnell Pharmaceuticals reported results for the first nine months of 2019. Sales reached Aus$21.8 million ($14.9 million), a 9% increase year-over-year. Total comprehensive loss for the nine-month period was Aus$(5.1) million compared to Aus$(4) million at the same point in 2018. (Animal Pharm)
  • Animalcare reported results for the full year 2019. Annual revenues were GBP 71.1 million ($93.4 million) for the fiscal year, a 1.5% decline compared to the prior year. (Animal Pharm)
  • PetMed Express, Inc. announced financial results for its third fiscal quarter ended December 31, 2019. Net sales were $59.9 million, flat compared to the prior-year quarter. Net income was $6.8 million compared to net income of $7.8 million in the prior-year quarter. (company website)
  • Creso Pharma reported results for the full year 2019. Unaudited revenues from nutraceutical and animal health product sales for the full year 2019 were nearly $2.8 million, up from about $550,000 for the full year 2018. The company also announced that, in collaboration with Virbac, it has now sold over three million Anibidiol (hemp oil) granule sachets since the product’s launch in 2017. (
  • UK-based National Veterinary Services reported financial results for its fiscal year ended April 30, 2019. Turnover was GBP 458 million ($595 million), an increase of 4% year-over-year. Pre-tax profits remained static at GBP 10.5 million ($13.7 million). (


Are pet product sales at an inflection point?

A new report from Brakke Consulting measures and characterizes the most dynamic changes taking place in the marketing of pet products – the emergence of new channels and the changing purchasing behaviors of pet owners, especially as it relates to products traditionally purchased at the veterinary clinic.

Pet Health Products: Changing Channels is based on two national, representative studies: one of over 1,000 pet owners, the other of over 550 companion animal veterinarians.  The data from these surveys are compared to data from previous Brakke studies in these areas to highlight trends.

This timely new report provides marketers and investors key insights to help:

  • Focus resources in the most productive areas
  • Build more effective defense strategies in key channels
  • Recalibrate channel strategies for principal products
  • Build innovative channel strategies for new products and categories
  • Design investment strategies based on “fishing where the fish are”

Pet Health Products, Changing Channels is now available for purchase.  Cost per report is $10,000.  For more information about this important study please contact at John Volk at or Bob Jones at



  • Elanco Animal Health announced it intends to make concurrent public offerings of 22,694,732 shares of its common stock (upsized from an offering size of 19,159,866 shares) at $32.00 per share and 11,000,000 of its 5.00% tangible equity units, with a stated amount of $50 per unit. Elanco intends to use the net proceeds from the offerings to finance a portion of the previously announced acquisition of Bayer AG’s animal health business and to pay related fees and expenses. (company press release)
  • Merck Animal Health announced the results of a comprehensive study of wellbeing and mental health among U.S. veterinarians. Conducted by Brakke Consulting, in collaboration with the American Veterinary Medical Association (AVMA), the Merck Animal Health Veterinarian Wellbeing Study also examined job satisfaction, compensation, burnout, substance use disorder, cyberbullying and suicide among veterinarians while evaluating potential solutions. For more information, go to (company website)
  • IDEXX Laboratories, Inc. announced the launch of IDEXX Digital Cytology, a new service that digitally connects veterinarians to a network of more than 100 veterinary clinical pathologists and enables them to receive cytology interpretations within 2 hours, 24 hours a day, 7 days a week, 365 days a year. The service is powered by a new in-clinic instrument and IDEXX’s proprietary VetConnect PLUS software. (company press release)
  • Dechra announced the launch of Vetradent Rawhide Dental Chews for Dogs and Vetradent Toothpaste for Dogs and Cats. (DVM360)
  • Royal Canin announced the upcoming launch Blücare Litter Granules from Royal Canin. Pet owners sprinkle the white granules into their cat’s litter; if the granules turn blue after the cat urinates, there is blood in the cat’s urine. (DVM360)
  • Purina Pro Plan Veterinary Supplements announced the upcoming launch of HydraCare, a nutrient-enriched water formulation that helps cats consume 28% more liquid each day than plain water alone. (DVM360)
  • Patterson Veterinary announced an exclusive partnership with GlobalVetLink (GVL) for the latter’s veterinary management system. GVL’s cloud-based platform connects veterinarians, pet owners and state animal health officials to provide health certificates for animals while traveling. (Animal Pharm)
  • Anubis Bio Corporation announced the launch of DoggyStat acute canine diarrhea relief. Targeted antibodies actively neutralize bacterial and viral pathogens to the GI tract to support normal gut function and relieve diarrhea in 12 to 24 hours with a single dose, with no known side effects. (DVM360)
  • Nationwide announced the launch of pet insurance for avian and exotic pet owners. (DVM360)
  • Vetsource announced it has renewed its contract with Veterinary Study Groups, Inc. (VSG) as a preferred Home Delivery provider for its more than 1,400 member practices. (company press release)
  • whiskerDocs announced the allowance of its system patent, “Systems and Methods for Decision Support for Animal Health Queries” by the US Patent office. The patent covers the complex scoring algorithms and delivery of pet tele-health protocols necessary to provide pet owners the neutral, unbiased support they need when something is happening with their pet. (
  • WebMD announced the launch of Fetch, a new branch of the site specifically geared toward pet-related content. The new resource is available at (Vet Advantage)
  • The North American Veterinary Community (NAVC) announced the launch of “embrace” (, an advocacy program that gives veterinary professionals and pet owners a platform to advocate for animals everywhere. “embrace” launches with an immediate call to action in support of National Animal Rescue Day (H.R. 34); Strengthening Support for Veterans with Service Animals Act (H.R. 4952); and The Puppies Assisting Wounded Service Members (PAWS) Act (H.R. 3103 and S. 2949). (PRnewswire)
  • EU QBiotics Group Limited announced the first registration for its small molecule, tigilanol tiglate, with the European Medicines Agency (EMA) approval of Stelfonta as an oncology veterinary pharmaceutical. Stelfonta is indicated for the treatment of non-resectable, non-metastatic subcutaneous Mast Cell Tumors (MCT) located at or distal to the elbow or the hock, and non-resectable, non-metastatic cutaneous MCT in dogs. Stelfonta will be marketed in the EU by Virbac. (Yahoo finance, Animal Pharm)
  • CANADA SomaDetect announced that it has received Can$3.9 million ($2.9 million) from Sustainable Development Technology Canada (SDTC) to pilot its automated dairy cow sensor technology across North America. (Animal Pharm)



 *Thursday market closing prices



  • CHINA – PORK PRODUCTION The National Bureau of Statistics reported that China produced 42.55 million tons of pork in 2019, down 21.3% from 2018 and the country’s lowest pork output since 2003. The country is experiencing a shortage of more than 10 million metric tons of pork. (Feed Strategy)
  • US – EUTHANASIA GUIDELINES The American Veterinary Medical Association (AVMA) released the latest version of its “Guidelines for the Euthanasia of Animals.” The new guidelines are an update to AVMA’s 2013 version and are available on the AVMA website at (Feedstuffs)


JANUARY 18-22, 2020
Over 18,000 veterinarians, staff, exhibitors and guests attended the VMX Veterinary Meeting & Expo in Orlando, Florida this week. Attendees chose from more than 1,200 CE credit hours and enjoyed approximately 700 vendors in the Exhibit Hall.  Concurrent with the conference, VMX launched the VMX Virtual Expo, enabling veterinarians to engage with VMX exhibitors 24/7, 365 days a year.

It was cold in Orlando this week at the NAVC’s VMX Veterinary Meeting & Expo, but the Convention Center had the heat on, so we all survived.  Over 18,000 people did more than survive – we met old friends, made new ones, and learned.  In the discussions the Brakke team had, we learned that some of you are glad 2019 is behind us.

We now know a little about what is ahead of us in 2020.  There were a few significant product launches at VMX, but if you operate in the canine parasiticide world, there was a lot of talk about a product not yet registered in the US, Zoetis’s Simparica Trio, which adds heartworm prevention and gastrointestinal nematode control to flea and tick control.  We expect further innovation in the parasiticide space with long acting formulations and novel injectable, oral and topical combination products.  These new combination products will give veterinarians and pet owners alike options for the control of parasites.  And options are always good.

A significant wellbeing study from Brakke and Merck was announced at VMX – it is worth clicking on the link above.  We can all learn from this study – and that’s good, too.

Bob Jones


Trouble viewing this newsletter?  You can view it online at
This electronic newsletter is the sole property of Brakke Consulting.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting.
For more information about Brakke Consulting’s services and syndicated studies, visit our website at

Brakke Consulting
806 Green Valley Rd
Suite 200
Greensboro, NC  27408

en_USEnglish (United States)